Odanacatib
98%
- Product Code: 103331
CAS:
603139-19-1
| Molecular Weight: | 525.564 g./mol | Molecular Formula: | C₂₅H₂₇F₄N₃O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11042419 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Odanacatib is primarily used in the treatment of osteoporosis, particularly in postmenopausal women. It works by inhibiting cathepsin K, an enzyme involved in the breakdown of bone tissue. By blocking this enzyme, it helps to reduce bone resorption, thereby maintaining bone density and strength. This makes it effective in lowering the risk of fractures and improving overall bone health. It has been studied extensively in clinical trials for its potential to offer a long-term therapeutic option for managing osteoporosis with less frequent dosing compared to other treatments.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿954.00 |
+
-
|
Odanacatib
Odanacatib is primarily used in the treatment of osteoporosis, particularly in postmenopausal women. It works by inhibiting cathepsin K, an enzyme involved in the breakdown of bone tissue. By blocking this enzyme, it helps to reduce bone resorption, thereby maintaining bone density and strength. This makes it effective in lowering the risk of fractures and improving overall bone health. It has been studied extensively in clinical trials for its potential to offer a long-term therapeutic option for managing osteoporosis with less frequent dosing compared to other treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :